Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment

IntroductionOvarian cancer is the most lethal gynecological malignancy. Deepening our knowledge of the interactions within the tumor microenvironment (TME) is important for discovering new targeted treatment strategies. Transglutaminase 2 (TG2) is a protein implicated in many biological and pathophy...

Description complète

Détails bibliographiques

Auteurs principaux:	Dalia Ibrahim, Melanie Grondin, Kristianne Galpin, Sara Asif, Emily Thompson, Sarah Nersesian, John Abou-Hamad, Maryam Echaibi, Galaxia M. Rodriguez, Pauline Navals, Elizabeth Macdonald, Brianna Ryan, David P. Cook, Jeffrey W. Keillor, Barbara C. Vanderhyden
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2025-07-01
Collection:	Frontiers in Immunology
Sujets:	ovarian cancer transglutaminase 2 immune modulation targeted therapy metastasis
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1639853/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!